Buy Synvisc Online

(Hylan G-F 20)

The active ingredient in Synvisc is hylan G-F 20.

Hylan G-F 20 is a form of hyaluronan that is designed to mimic the natural lubricating fluid found in healthy joints. In people with osteoarthritis of the knee, the synovial fluid becomes thinner and less effective.

When Synvisc is injected into the knee joint, it helps restore the cushioning and lubricating properties of the synovial fluid. This can reduce friction between bones, improve joint movement, and provide pain relief.

By improving joint lubrication and shock absorption, Synvisc may help reduce knee pain and improve mobility during daily activities and weight-bearing activities.

Follow all directions given to you by your doctor and read all documents provided, including the full Prescribing Information, FDA-Approved Product Labeling, Instructions for Use, and Medication Guide before using Synvisc. However, the following is a synopsis of the general guidelines for the use of Synvisc:

• Synvisc is administered as an intra-articular injection into the knee joint by a healthcare professional.
• The injection is given using a sterile syringe under medical supervision.
• Treatment may consist of a series of injections or a single injection, depending on the formulation.
• Synvisc-One is designed as a single injection treatment for osteoarthritis of the knee.
• Other Synvisc treatments may involve multiple injections given several weeks apart.
• After receiving the injection, patients should avoid strenuous activities and heavy weight-bearing activities for several days.
• Activities such as jogging, tennis, or heavy lifting should be limited for a short period after the injection.
• Your healthcare provider will determine the appropriate treatment schedule based on your symptoms and medical history.

Some mild or common side effects of Synvisc seen in clinical trials include:

• Injection site pain.
• Swelling in the injected knee.
• Joint stiffness.
• Fluid build-up in the knee joint.
• Mild knee pain or discomfort.

Some individuals may experience serious side effects while using $Drugname. These side effects may require immediate medical attention. If you experience any of the following, contact your healthcare provider or seek emergency medical help:

• Severe allergic reactions, including hives or swelling.
• Severe knee swelling or joint effusion.
• Signs of joint infection, such as fever, redness, or warmth at the injection site.
• Severe pain (arthralgia) or inability to move the knee after the injection.

Disclaimer: These are not all of the possible adverse events of Synvisc. You should always seek medical advice from your healthcare provider for any questions or concerns about your medical condition or treatment. Read all patient information, medication guides, or drug information sheets that come with this medication. You can also report adverse effects to the Food and Drug Administration at www.fda.gov/medwatch or 1-800-FDA-1088.

Before starting Synvisc, it is crucial to discuss any existing health conditions with your healthcare provider. You should be sure that your healthcare provider is aware of all your medical conditions, including if you have:

• Allergies to hyaluronan products or egg products.
• Skin disease or infections near the injection site.
• Joint infection or inflammation in the knee joint.
• A history of allergic reactions to injectable medications.

Synvisc should not be used in patients with:

• Known hypersensitivity to hylan polymers or hyaluronan products.
• Active joint infection or skin disease at the injection site.

The injection should not be given in areas with active inflammation or infection.

Pain relief from Synvisc may not occur immediately after the injection. Some patients begin to notice improvement in knee pain within several weeks after treatment.

Clinical studies have shown that the benefits may last for several months, depending on the individual patient and the severity of osteoarthritis.

When Synvisc is taken with other prescription drugs, over-the-counter medications, vitamins, and supplements, it may change how they work or increase the frequency or severity of side effects. Make sure that you tell your healthcare professional about anything that you are taking to avoid any negative drug interactions, including:

• NSAIDs, or non-steroidal anti-inflammatory drugs, are used for pain relief.
• Acetaminophen or other analgesics are used for osteoarthritis pain.
• Over-the-counter pain relievers or supplements taken for joint health.

These medications are often used together with Synvisc to help manage osteoarthritis symptoms, but your healthcare provider should review your treatment plan.

Synvisc is available as a sterile injection containing hylan G-F 20.

Typical dosing includes:

• Synvisc is administered as a series of three intra-articular injections into the knee joint, usually given one week apart.
• Synvisc-One is administered as a single injection for osteoarthritis of the knee.

The exact dosing schedule will be determined by your healthcare provider. The safety and effectiveness of Synvisc have not been established in patients ≤21 years old or in pregnant or lactating women.

It should be stored at room temperature, away from the reach of children or pets.

Synvisc is manufactured by Genzyme Corporation, a company that is part of Sanofi.

There is currently no direct generic version of Synvisc available. However, other viscosupplementation products containing hyaluronate may be available as alternatives.

Synvisc is not taken daily. It is given as a scheduled injection by a healthcare provider. Once the treatment course is complete, no further doses are required unless your healthcare provider recommends additional injections in the future.

Talk to your doctor if you are already pregnant or if you have any plans to become pregnant. Your healthcare provider will weigh the potential risks and benefits before recommending treatment during pregnancy.

Talk to your doctor if you are already breastfeeding or if you have any plans to breastfeed. Your healthcare provider will recommend the safest treatment option.